AzTrials
AzTrials

Preoperative AnxietySilvaNCT04379882

Feasibility Study Evaluating the Silva Module During the Anaesthesiology Consultation Before an Elective Surgery

A study testing Digital Sedation (Silva) in people with Preoperative Anxiety, run by Oncomfort.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

In this feasibility study, feasibility, acceptability and an initial clinical efficacy of the new module of Hypnosis and Virtual Reality (or Digital Sedation), Silva, will be evaluated. This feasibility study meets objectives of Oncomfort's design validation and design verification steps. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Preoperative Anxiety
What is being tested?
Digital Sedation (Silva)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
10 Nov 2020to 20 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Subject more than 18 years old

Who cannot join

  • Deaf subject
  • Blind
  • Non-proficiency in French (Module language)
  • Psychiatric disorder
  • Head or face wounds
  • Neurological disease
Show all 9Show fewer
  • Chronic pain and/or chronic analgesics consumption
  • Medication affecting the autonomic nervous system
  • Dizziness

About this study

In this feasibility study, feasibility, acceptability and an initial clinical efficacy of the new module of Hypnosis and Virtual Reality (or Digital Sedation), Silva, will be evaluated. This feasibility study meets objectives of Oncomfort's design validation and design verification steps. Silva will be tested on a sample of 10 patients in the environment where the product is intended to be used, a hospital environment. If results do not fit with user needs, design will be adapted according to results and a new phase of design validation will be implemented. The Silva module is a Digital Sedation module designed for management of pain and anxiety in perioperative patients.

Read the detailed description

Subjects will be recruited during the anaesthesiology consultation preparing to an elective surgery.

First, subject will be asked to self-assess anxiety and comfort. In order to evaluate anxiety, subject will use a 0-10 rating Visual Analogue Scale (VAS) where 0 = no anxiety at all, and 10= the worst imaginable anxiety. The same scale will be used to measure the level of comfort where 0 means no comfort at all and 10 very comfortable.

Subject should be positioned laying on a reclining chair during the session. This session will last for 30 minutes. After the experiment, participants will be asked to rate anxiety, level of comfort, level of immersion and dissociation.

Several questions will be asked to the patient to evaluate his/ her experience, the Silva module, and the sensations experienced.

The study will be ended by an evaluation of adverse event (AE) and the evaluation of the caregivers.

Being tested
Digital Sedation (Silva)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital Sedation (Silva)Device

    Use of Digital Sedation (virtual reality associated with psychological interventions) for preoperative anxiety management

Study groups in NCT04379882
Study groupRoleWhat they receive
Digital sedationExperimental30 minutes Silva module
Receives: Device: Digital Sedation (Silva)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the acceptability and the patient's qualitative reported experience of Silva

    questionnaire

    Measured: Day 1 of the intervention

Secondary outcomes (3)
  1. Evaluate Anxiety

    questionnaire VAS 0 (no anxiety)- 10 (max anxiety)

    Measured: Day 1 of the intervention

  2. Evaluate Comfort

    questionnaire VAS 0 (extreme discomfort)- 10 (extreme comfort)

    Measured: Day 1 of the intervention

  3. Evaluation of agreeability of the Digital Sedation session

    questionnaire VAS (0-10) 0: not agreeable, 10: extremely agreeable

    Measured: Day 1 of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2020
  2. Study start10 Nov 2020 (estimated)
  3. Primary completion10 Dec 2020 (estimated)
  4. Study completion20 Dec 2020 (estimated)

Why it stopped: Decision of alternative research to be performed

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04379882
Sponsor's protocol ID
OC32 Silva
Acronym
Silva
Status last verified
Jun 2021
First submitted
17 Apr 2020
Last updated
30 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Digital Sedation (Silva) in people with Preoperative Anxiety, run by Oncomfort.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 30 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the acceptability and the patient's qualitative reported experience of Silva (time frame: Day 1 of the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in